Industry / China
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
APP Pharma Finds Comfort In Heparin
March 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Baxter's heparin production problems appear to have given a boost to APP Pharmaceuticals, which had been expecting a tough year after it parted company with its biotech interests Abraxis BioScience in November 2007. As part of the split, APP took on US$1bn debt, which was expected to weigh on the company while it brought its new Puerto Rican facility up to capacity. As it turns out, it has been a case of the right product at the right time for APP, as the new factory has given APP the slack to capitalise on Baxter's crisis and increase